Form 4: DarioHealth CEO Raphael Erez Increases Stake in Company
SEC Form 4 Filing
DarioHealth Corp. CEO Raphael Erez recently purchased additional shares of the company's common stock, signaling confidence in its future.
Summary
- Raphael Erez, the CEO of DarioHealth Corp., has reported changes in his beneficial ownership of the company's stock.
- On August 16, 2024, Erez purchased 2,000 shares at $0.89 and 3,000 shares at $0.90.
- On August 19, 2024, he further acquired 5,000 shares at $0.90.
- Following these transactions, Erez directly owns 1,922,059 shares of common stock.
- Additionally, he indirectly owns 37,876 shares through Dicilyon Consulting and Investment Ltd., over which he has voting and dispositive power via a proxy but disclaims beneficial ownership.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, which is generally viewed favorably by investors.
Positives
- The CEO's purchase of additional shares may be interpreted as a positive signal, indicating confidence in the company's prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued or that the company is poised for growth. It's a common practice monitored by investors.
Stakeholder Impact
- Shareholders may view the CEO's stock purchases as a positive signal, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Erez purchased 2,000 shares at $0.89 and 3,000 shares at $0.90. |
| 08/19/2024 | Erez purchased 5,000 shares at $0.90. |
| 08/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.